Found: 49
Select item for more details and to access through your institution.
Delphi consensus for the third-line treatment of metastatic colorectal cancer.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 6, p. 1429, doi. 10.1007/s12094-023-03369-1
- By:
- Publication type:
- Article
Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 1, p. 98, doi. 10.1007/s12094-023-03225-2
- By:
- Publication type:
- Article
SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022).
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 9, p. 2718, doi. 10.1007/s12094-023-03199-1
- By:
- Publication type:
- Article
Current professional standing of young medical oncologists in Spain: a nationwide survey by the Spanish Society of Medical Oncology + MIR section.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 3, p. 796, doi. 10.1007/s12094-022-02989-3
- By:
- Publication type:
- Article
A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 118, doi. 10.3390/ijms24010118
- By:
- Publication type:
- Article
The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1272561
- By:
- Publication type:
- Article
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR.
- Published in:
- Nature Medicine, 2015, v. 21, n. 7, p. 741, doi. 10.1038/nm.3863
- By:
- Publication type:
- Article
First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 674, doi. 10.1007/s10637-018-0674-x
- By:
- Publication type:
- Article
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921992974
- By:
- Publication type:
- Article
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921992974
- By:
- Publication type:
- Article
Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920936089
- By:
- Publication type:
- Article
Phase II Open-Label Study to Assess Efficacy and Safety of Lenalidomide in Combination with Cetuximab in <i>KRAS</i>-Mutant Metastatic Colorectal Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0062264
- By:
- Publication type:
- Article
Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12153-5
- By:
- Publication type:
- Article
ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 4, p. 827, doi. 10.1007/s00262-022-03283-5
- By:
- Publication type:
- Article
Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 412, doi. 10.3390/cancers16020412
- By:
- Publication type:
- Article
Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4245, doi. 10.3390/cancers15174245
- By:
- Publication type:
- Article
Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications.
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4020, doi. 10.3390/cancers15164020
- By:
- Publication type:
- Article
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13 , 1941.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6311, doi. 10.3390/cancers13246311
- By:
- Publication type:
- Article
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1941, doi. 10.3390/cancers13081941
- By:
- Publication type:
- Article
Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre network.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 9, p. 1908, doi. 10.1002/1878-0261.13444
- By:
- Publication type:
- Article
Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 9, p. 1827, doi. 10.1002/1878-0261.12547
- By:
- Publication type:
- Article
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 9, p. 1263, doi. 10.1002/1878-0261.12099
- By:
- Publication type:
- Article
Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49867-7
- By:
- Publication type:
- Article
The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
First-Line Treatment of Metastatic Colorectal Cancer: Interpreting FIRE-3, PEAK, and CALGB/SWOG 80405.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Current Options for Third-line and Beyond Treatment of Metastatic Colorectal Cancer. Spanish TTD Group Expert Opinion.
- Published in:
- Clinical Colorectal Cancer, 2020, v. 19, n. 3, p. 165, doi. 10.1016/j.clcc.2020.04.003
- By:
- Publication type:
- Article
COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 6, p. 1005, doi. 10.1038/s41416-024-02796-3
- By:
- Publication type:
- Article
Correction To: Liver transplantation in metastatic colorectal cancer: are we ready for it?
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Liver transplantation in metastatic colorectal cancer: are we ready for it?
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 10, p. 1797, doi. 10.1038/s41416-023-02213-1
- By:
- Publication type:
- Article
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Nivolumab Plus Ipilimumab vs Chemotherapy as First-Line Treatment for Microsatellite Instability-High/Mismatch Repair--Deficient Metastatic Colorectal Cancer: Expanded Efficacy Analysis From Checkmate 8HW.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2024, v. 15, n. 10, p. 313
- By:
- Publication type:
- Article
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1209, doi. 10.1093/oncolo/oyad210
- By:
- Publication type:
- Article
BRAF<sup>V600E</sup>/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. 771, doi. 10.1093/oncolo/oyad082
- By:
- Publication type:
- Article
Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 230, doi. 10.1093/oncolo/oyad007
- By:
- Publication type:
- Article
Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1112276
- By:
- Publication type:
- Article
Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1021772
- By:
- Publication type:
- Article
Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Targeting KRAS G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 6, p. 3304, doi. 10.3390/ijms25063304
- By:
- Publication type:
- Article
Pembrolizumab in Asian patients with microsatellite‐instability‐high/mismatch‐repair‐deficient colorectal cancer.
- Published in:
- Cancer Science, 2023, v. 114, n. 3, p. 1026, doi. 10.1111/cas.15650
- By:
- Publication type:
- Article
EGFR Amplification in Metastatic Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 1, p. 1, doi. 10.1093/jnci/djt322
- By:
- Publication type:
- Article
Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0189848
- By:
- Publication type:
- Article
Encorafenib plus cetuximab for the treatment of BRAF-V600E -mutated metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Gastroenterology, 2022, v. 15, p. 1, doi. 10.1177/17562848221110644
- By:
- Publication type:
- Article